These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 8507366)
1. An alternative treatment of massive burns: skin allografts and cyclosporin immunosuppression without severe additional depression of cell-mediated immunity in an animal model. Cetinkale O; Senyuva C; Ayan F; Cokneseli B; Pusane A Burns; 1993 Jun; 19(3):215-9. PubMed ID: 8507366 [TBL] [Abstract][Full Text] [Related]
2. The use of FK506 and skin allografting for the treatment of severe burns in an animal model. Cetinkale O; Cizmeci O; Ayan F; Senyuva C; Pusane A Br J Plast Surg; 1993 Jul; 46(5):410-5. PubMed ID: 7690295 [TBL] [Abstract][Full Text] [Related]
3. The effect of antioxidant therapy on cell-mediated immunity following burn injury in an animal model. Cetinkale O; Senel O; Bulan R Burns; 1999 Mar; 25(2):113-8. PubMed ID: 10208384 [TBL] [Abstract][Full Text] [Related]
4. Early wound excision and skin grafting restores cellular immunity after severe burn trauma. Cetinkale O; Ulualp KM; Ayan F; Düren M; Cizmeci O; Pusane A Br J Surg; 1993 Oct; 80(10):1296-8. PubMed ID: 8242303 [TBL] [Abstract][Full Text] [Related]
5. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model. Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppression following excision of burn eschar and syngeneic grafting in major thermal trauma. Jacobson BK; Baker CC Yale J Biol Med; 1984; 57(5):797-808. PubMed ID: 6240833 [TBL] [Abstract][Full Text] [Related]
8. Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts. Hultman CS; Cairns BA; deSerres S; Frelinger JA; Meyer AA Transplantation; 1995 Sep; 60(6):584-9. PubMed ID: 7570955 [TBL] [Abstract][Full Text] [Related]
9. Effects of combined radiation and thermal burn injury on the survival of skin allograft and immune function in rats. Ran X; Yan Y; Cheng T; Lin Y; Wei S; Zheng H Chin Med J (Engl); 1998 Jul; 111(7):634-7. PubMed ID: 11245052 [TBL] [Abstract][Full Text] [Related]
10. Short-course cyclosporin A therapy for definite allograft valve survival immunosuppression in allograft valve operations. Yankah AC; Wottge HU; Müller-Ruchholtz W Ann Thorac Surg; 1995 Aug; 60(2 Suppl):S146-50. PubMed ID: 7646147 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine and skin allografts for the treatment of thermal injury. II. Development of an experimental massive third-degree burn model demonstrating extensive graft survival. Black KS; Hewitt CW; Smelser S; Yearsley S; Bazzo DE; Achauer BM Transplantation; 1988 Jan; 45(1):13-6. PubMed ID: 3276041 [TBL] [Abstract][Full Text] [Related]
12. Improved large burn therapy with reduced mortality following an associated septic challenge by early excision and skin allografting using donor-specific tolerance. Garrison JL; Thomas F; Cunningham P Transplant Proc; 1995 Feb; 27(1):1416-8. PubMed ID: 7878931 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A treatment failed to extend skin allograft survival in two burn patients. Eldad A; Benmeir P; Weinberg A; Neuman A; Chaouat M; Ben-Bassat H; Wexler MR Burns; 1994 Jun; 20(3):262-4. PubMed ID: 8054144 [TBL] [Abstract][Full Text] [Related]
15. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
16. Long-term survival of human skin allografts in patients with immunosuppression. Wendt JR; Ulich T; Rao PN Plast Reconstr Surg; 2004 Apr; 113(5):1347-54. PubMed ID: 15060346 [TBL] [Abstract][Full Text] [Related]
17. Prolonged allograft survival in a patient with extensive burns using cyclosporin. Mindikoğlu AN; Cetinkale O Burns; 1993 Feb; 19(1):70-2. PubMed ID: 8435121 [TBL] [Abstract][Full Text] [Related]
18. Skin allograft and vascularized composite allograft: potential for long-term efficacy in the context of lymphatic modulation. Rinkinen J; Selley R; Agarwal S; Loder S; Levi B J Burn Care Res; 2014; 35(5):355-61. PubMed ID: 25051523 [TBL] [Abstract][Full Text] [Related]
19. Comparison of regeneration across nerve allografts with temporary or continuous cyclosporin A immunosuppression. Midha R; Mackinnon SE; Evans PJ; Best TJ; Hare GM; Hunter DA; Falk-Wade JA J Neurosurg; 1993 Jan; 78(1):90-100. PubMed ID: 8416248 [TBL] [Abstract][Full Text] [Related]
20. Preclinical assessment of safety and efficacy of intravenous delivery of autologous adipose-derived regenerative cells (ADRCs) in the treatment of severe thermal burns using a porcine model. Foubert P; Liu M; Anderson S; Rajoria R; Gutierrez D; Zafra D; Tenenhaus M; Fraser JK Burns; 2018 Sep; 44(6):1531-1542. PubMed ID: 29958745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]